European CHMP recommends netarsudil and latanoprost ophthalmic solution (Roclanda) for primary open-angle glaucoma or ocular hypertension

The positive opinion is for the reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Source:

European Medicines Agency